Clinical Trials Browser

INDUSTRY × Fatigue × Clear all

NCT06989437 2026-02-06

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Phase 2/3 Recruiting

Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT07033559 2026-01-28

Detecting Fatigue From Voice in Generalised Myasthenia Gravis

Not yet recruiting

Fatigue, Myasthenia Gravis

NCT06754722 2026-01-16

Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors

Phase NA Recruiting

Fatigue, Parasomnias

NCT06137833 2025-10-01

Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy

Phase NA Recruiting

Breast Neoplasms, Fatigue

NCT00518869 2025-06-04

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung, Fatigue

NCT02077621 2025-06-04

Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

Phase 2 Withdrawn

Fatigue, Neoplasms

NCT05546476 2025-05-31

PROACC-1

Phase 2 Completed

187 enrolled 24 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT05212701 2024-04-30

To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Fatigue

NCT05664009 2024-04-05

The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

Phase 2 Recruiting

Fatigue, Neoplasms, Second Primary

NCT05852002 2024-01-17

A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer

Phase NA Completed

Cough, Fatigue, Pain

NCT04803305 2024-01-12

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Phase 1 Completed

18 enrolled 14 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Anorexia, Breast Neoplasms, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04299048 2023-12-14

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Phase 1 Completed

11 enrolled 13 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Muscular Atrophy, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis

NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

Phase 2 Completed

Cachexia, Fatigue, Lung Neoplasms

NCT02434367 2017-12-14

WWE

Phase 2 Completed

Breast Neoplasms, Fatigue, Neoplasms

NCT00825227 2017-11-17

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Phase 2 Terminated

10 enrolled 7 charts

Fatigue, Neoplasms

NCT02645175 2016-10-21

Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue

Phase 2 Terminated

Breast Neoplasms, Fatigue

NCT01160380 2014-11-06

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Phase 3 Completed

50 enrolled 14 charts

Fatigue, Multiple Myeloma, Neoplasms

NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Phase 2 Unknown

Anorexia, Fatigue, Weight Loss

NCT00758407 2010-01-13

EMF

Phase 2/3 Completed

Fatigue, Neoplasms

NCT00047476 2005-06-24

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Phase 2 Completed

Chemotherapy-Related Cognitive Impairment, Fatigue, Memory Disorders, Neoplasms